Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Reexamination Certificate
1998-01-23
2003-11-18
Swartz, Rodney P (Department: 1645)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
C424S185100, C424S192100, C424S263100, C435S006120, C435S069100, C435S071100, C435S091200, C530S350000, C536S023100, C536S023400, C536S023700
Reexamination Certificate
active
06649374
ABSTRACT:
FIELD OF THE INVENTION
A new recombinant form of the plasmid-encoded protein pgp3 from
C. trachomatis
, serotype D, was purified by ion exchange column chromatography and shown to be suitable for quantitative immunoassay on clinical samples in an ELISA format. Since initial attempts of developing a similar assay with a SDS-denatured pgp3-fusion protein failed, the results suggest that for anti-pgp3 antibody detection, antigen conformation is important.
BACKGROUND OF THE INVENTION
The function of the 7.5 kb plasmid, pCT, of
Chlamydia tyachomatis
is still unknown. However in fact that this DNA element appears to be strongly conserved in
C. trachomatis
(both in terms of its presence in essentially all isolates and in terms of is genetic structure) suggests that pCT may provide some, important, and perhaps advantageous, function to the chlamydial cell during its natural host infection. Recently, an open reading frame of pCT (ORF3; Comanducci et al.,
Plasmid
, 23:149-154, 1990) was expressed in
E. coli
as a recombinant fusion protein (Comanducci et al.,
J. Gen. Microbiology
, 134:1083-1092, 1993). The expression system used added a 11-kDa N-terminal polypeptide of the MS2-bacteriophage polymerase to the 28-kDa polypeptide (pgp3) encoded by ORF3. The resulting 39-kDa product was used to show that pgp3 epitopes can be recognized on Western blots by antibodies present in sera from patients with chlamydial infections, but not in control sera from healthy donors. Following this observation, we subsequently tried to develop a serological test more suitable than the immunoblotting technique for obtaining reproducible and quantitarive data from large numbers of clinical samples. We now report that an enzyme-linked immunoassay based on a new recombinant form of the pgp3 protein, can be used for assessing the prevalence of pgp3 antibodies in people with
C. trachomatis
infections.
REFERENCES:
patent: 4336336 (1982-06-01), Silhavy et al.
patent: 4546083 (1985-10-01), Meyers et al.
patent: 4551433 (1985-11-01), DeBoer
patent: 4588684 (1986-05-01), Brake
patent: 4683195 (1987-07-01), Mullis et al.
patent: 4683202 (1987-07-01), Mullis
patent: 4689406 (1987-08-01), Banks et al.
patent: 4738921 (1988-04-01), Belagaje et al.
patent: 4745056 (1988-05-01), Guterman et al.
patent: 4837148 (1989-06-01), Cregg
patent: 4870008 (1989-09-01), Brake
patent: 4876197 (1989-10-01), Burke et al.
patent: 4880734 (1989-11-01), Burke et al.
patent: 4880911 (1989-11-01), Brewer et al.
patent: 4929555 (1990-05-01), Cregg et al.
patent: 6110705 (2000-08-01), Ratti et al.
patent: 036259 (1981-09-01), None
patent: 036776 (1981-09-01), None
patent: 060057 (1982-09-01), None
patent: 121775 (1984-10-01), None
patent: 127839 (1984-12-01), None
patent: 136829 (1985-04-01), None
patent: 136907 (1985-04-01), None
patent: 155476 (1985-09-01), None
patent: 164556 (1985-12-01), None
patent: 196056 (1986-10-01), None
patent: 219237 (1987-04-01), None
patent: 293079 (1987-04-01), None
patent: 244042 (1987-11-01), None
patent: 267851 (1988-05-01), None
patent: 284044 (1988-09-01), None
patent: WO 90/14837 (1989-05-01), None
patent: 324274 (1989-07-01), None
patent: 324647 (1989-07-01), None
patent: 329203 (1989-08-01), None
patent: 449681 (1992-08-01), None
patent: 0-499681 (1992-08-01), None
patent: 62-96086 (1987-05-01), None
Kahane et al, “Cloning, characterization and sequence of a novel 59-kDa protein of Chlamydia trachomatis”, Gene, vol. 90, No. 1, pp. 61-67, Jan. 1, 1990.*
Comanducci, M. et al., “Diversity of theChlamydia trachomatisCommon Plasmid in Biovars with Different Pathogenicity”,Plasmid, 1990, 23, 149-154.
Comanducci, M. et al., “Expression of a Plasmid Gene ofChlamydia trachomatisEncoding a Novel 28 kDa Antigen”,J. Gen. Microbiology, 1993, 139, 1083-1092.
Tabor, S. and Richardson, “A Bacteriophage T7 RNA Polymerase/Promoter System for Controlled Exclusive Expression of Specific Gene”,PNAS USA, 1985, 82, 1074-1078.
Birkelund, S., “The Molecular Biology and Diagnostics ofChlamydia trachomatis”, Dan. Med. Bull., 1992, 39(4), 304-320.
Harlowe et al., “Antibodies: A Laboratory Manual”, Cold Spring Harbor Laboratory, Cold Spring, New York, pp. 33-34, 564, 1988.
Clark et al., “Enzyme linked Immunsorbent Assay (FUSA): Theoretical and Practical Aspects”, in “Enzyme-Immunoassay”, CRC Press, Inc., pp. 167-179, 1987.
Comanducci, M. et al., “Identification and Characterization of a 28-Kd Protein ofC.trachomatisEncoded by the 7.5-Kb Commn Plasmid”, International Symposium on Human Chlamydial infections, Jun. 24-29, 1990, 121-124.
Morrison et al., “Immunology ofChlamydia trachomatisInfections Immunoprotective and Immunopathogenetic Responses”, in Sexually Transmitted Diseases, Quinn, T. Ed., Raven Press, Ltd, New York, pp. 57-84, 1992.
Zhan, Y.-X. et al., “Protective Monoclonal Antibodies toChlamydia trachomatisSerovar-and Serogroup-Specific Major Outer Membrane Protein Determinants”,Infect. Immun., 1989, 57(2), 636-638.
Allen, G. et al., “Synthesis and Cloning of a Gene Coding for a Fusion Protein Containing Mouse Epidermal Growth Factor”,J. Biotech., 1987, 5, 93-114.
Amann, E. et al., “Vectors Bearing a Hybrid trp-lac Promoter Useful for Regulated Expression of Cloned Genes inEscherichia coli”, Gene, 1983, 25, 167-178.
Amann, E. And Brosius, “A‘ATG Vectors’ for Regulated High-Level Expression of Cloned Genes inEscherichia coli”, Gene, 1985, 40, 183-190.
Augustin, J. and Götz, “Transformation ofStaphylococcus epidermidisand Othe Staphylococcal Species with Plasmid DNA by Electroporation”,FEMS Microbiol. Lett., 1990, 66, 203-208.
Ausubel, ed., “Current Protocols in Molecular Biology”, vol. 2, John Wiley & Sons, 1994, Section 16.8.
Barany, F. And Tomasz, “Genetic Transformation ofStreptococcus pneumoniaeby Heterologous Plasmid Deoxyribonucleic Acid”,J. Bacteriol., 1980, 144, 698-709.
Beach, D. et al., “Functionally Homologous Cell Cycle Control Genes in Budding and Fission Yeast”,Nature, 1982, 300, 706-709.
Birnstiel, M.L. et al., “Transcription Termination and 3′-Processing: The End Is In Site!”,Cell, 1985, 41, 349-359.
Boshart M. et al., “A Very Strong Enhancer is Located Upstream of an Immediate Early Gene of Human Cytomegalovirus”,Cell, 1985, 41, 521-530.
Botstein, D. et al., “Sterile Host Yeasts (Shy): A Eukaryotic System of Biological Containment for Recombinant DNA Experiments”,Gene, 1979, 8, 17-24.
Brake, A. et al., “&agr;-Factor-Directed Synthesis and Secretion of Mature Foreign Proteins inSaccharomyces cerevisiae”, PNAS USA, 1984, 81, 4642-4646.
Butt, T. And Ecker, “Yeast Metallothionein and Applications in Biotechnology”,Microbiol. Rev., 1987, 51(3), 351-364.
Carbonell, L. et al., “Baculovirus-Mediated Expression of Bacterial Genes in Dipteran and Mammalian Cells”,J. Virology, 1985, 56(1), 153-160.
Carbonell, L. et al., “Synthesis of Gene Coding for an Insect-Specific Scorpion Neurotoxin and Attempts to Express Its Using Baculovirus Vectors”,Gene, 1988, 73, 409-418.
Cerrone, M. et al., “Cloning and Sequence of the Gene for Heat Shock Protein 60 fromChlamydia trachomatisand Immunological Reactivity of the Protein”,Infect. Immun., 1991, 59(1), 79-90.
Chassy, B. and Flickinger, “Transformation ofLactobacillus caseiby Electroporation”,FEMS Microbiology Letters, 1987, 44, 173-177.
Cohen, J. et al., “Functional Expression in Yeast of theEscherichia coliPlasmis Gene Coding for Chloramphenicol Acetyltransferase”,PNAS USA, 1980, 77(2), 1078-1082.
Cohen, S. et al., “Nonchromosomal Antibiotic Resistance in Bacterial: Genetic Transformation ofEscherichia coliby R-Factor DNA”,PNAS USA, 1972, 69(8), 2110-2114.
Cregg, J. et al., “Pichia pastorisas a Host System for Transformations”,Mol. Cell. Biol., 1985, 5(12), 3376-3385.
Das, S. et al., “Transformation ofKluyveromyces fragilis”, J. Bacteriol., 1984, 158(3), 1165-1167.
Davidow, L. et al., “Integrative Transformation of the YeastYarrowia lipolytica”, Curr. Genet., 1985, 10, 39-48.
Davies, J. and Smith, “Plasmid-Determined Resistance to Antimicrobial Agents”,Ann. Rev. Microbiol., 1978, 32, 469-518.
De Boer, H. et al., “The TAC Promoter: A Functional Hybrid Deriv
Blackburn Robert P.
Chiron S.r.l.
Hale Rebecca M.
Swartz Rodney P
LandOfFree
Recombinant Chlamydia trachomatis PGP3 antigen does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Recombinant Chlamydia trachomatis PGP3 antigen, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant Chlamydia trachomatis PGP3 antigen will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3169226